Evidence map›Paper›PMID 41131339›Full record

Articlenpj antimicrobials and resistance2025

Azole fungicides and Aspergillus resistance, five EU agency report highlights the problem for the first time using a One Health approach.

Michaela Lackner, Ana Alastruey-Izquierdo, Darius P H Armstrong-James, Michael J Bromley, Matthew C Fisher, Paul E Verweij

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in npj antimicrobials and resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Pathogenesis and Triazole Resistance inInfection and drug resistance · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Michaela LacknerMedical University of Innsbruck, Institute of Hygiene and Medical Microbiology, Innsbruck, Austria. Michaela.lackner@i-med.ac.at.
Ana Alastruey-IzquierdoMycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
Darius P H Armstrong-JamesDepartment of Infectious Disease Epidemiology, Imperial College London, London, UK.
Michael J BromleyManchester Fungal Infection Group, Division of Evolution, Infection, and Genomics, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Matthew C FisherMedical Research Council Centre for Global Disease Analysis, Imperial College London, London, UK.
Paul E VerweijDepartment of Medical Microbiology and Radboudumc Center of Expertise for Mycology, Radboud University Medical Center, Nijmegen, The Netherlands.

Funding

Medizinische Universität Innsbruck MU I DK-2023-1-1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41131339
PMCPMC12549888

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.